QSLS Politics

Wednesday, September 30, 2009

CG on Swine Flu Vaccination

In response to:
"Two days left to vote!!! Will you take a Vaccine to fight the Swine Flu???"on the Charles Leblanc blog
---
Magos wrote: Does anyone know the source of this ingredient list?

All I find are blogs linked to other sites without any links to the primary source. Unless I can verify the ingredient list from something linking to the primary source then I have no idea what is credible.
---
Dan F said...

I found some interesting tidbits going over the package inserts for one of the swine-flu vaccines approved by the FDA (http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM182401.pdf)

1. They have zero evidence that it or a similar vaccine work to prevent the flu "There have been no controlled clinical studies demonstrating a decrease in influenza disease after vaccination with AFLURIA"

2. "Thimerosal, a mercury derivative, is added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury"

3. It is being tested for adverse reactions against a placebo also containing mercury.

4. The drug maker's list of possible adverse reactions totally belies the soothing propaganda we've seen about this (unnecessary) vaccine in the media. I guess they've got their asses covered if it turns out disastrously:

- "Serious allergic reactions, including anaphylactic shock, have been observed during postmarketing surveillance in individuals receiving AFLURIA.
<...>
- The following adverse reactions also include those identified during postapproval use of AFLURIA outside the US since 1985.

Blood and lymphatic system disorders: Transient thrombocytopenia

Immune system disorders
Allergic reactions including anaphylactic shock and serum sickness

Nervous system disorders: Neuralgia, paresthesia, and convulsions; encephalopathy, neuritis or neuropathy, transverse myelitis, and GBS

Vascular disorders: Vasculitis with transient renal involvement

Skin and subcutaneous tissue disorders: Pruritus, urticaria, and rash

General disorders and administration site conditions: Influenza-like illness (e.g., pyrexia, chills, headache, malaise, myalgia), injection-site inflammation (e.g., pain, erythema, swelling, warmth), and induration
<...>

Neurological disorders temporally associated with influenza vaccination, such as encephalopathy, optic neuritis/neuropathy, partial facial paralysis, and brachial plexus neuropathy, have been reported.

Microscopic polyangiitis (vasculitis) has been reported temporally associated with influenza vaccination.
<...>

There are no data to assess the concomitant administration of Influenza A (H1N1) 2009 Monovalent Vaccine with other vaccines.
<...>

Animal reproduction studies have not been conducted with Influenza A (H1N1) 2009 Monovalent Vaccine or AFLURIA. It is also not known whether these vaccines can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
<...>

Neither Influenza A (H1N1) 2009 Monovalent Vaccine nor AFLURIA has been evaluated in children. Safety and effectiveness in the pediatric population have not been established.
<...>

Neither Influenza A (H1N1) 2009 Monovalent Vaccine nor AFLURIA has been evaluated for carcinogenic or mutagenic potential or for impairment of fertility."
---

Yeah - that all sounds real safe for a vaccine against a virus that is by all accounts far less deadly than the common flu.

No comments: